U.S. Markets close in 18 mins
  • S&P 500

    4,699.64
    +12.89 (+0.28%)
     
  • Dow 30

    35,751.35
    +31.92 (+0.09%)
     
  • Nasdaq

    15,769.24
    +82.33 (+0.52%)
     
  • Russell 2000

    2,275.45
    +21.67 (+0.96%)
     
  • Crude Oil

    72.58
    +0.53 (+0.74%)
     
  • Gold

    1,787.40
    +2.70 (+0.15%)
     
  • Silver

    22.49
    -0.04 (-0.17%)
     
  • EUR/USD

    1.1358
    +0.0086 (+0.7610%)
     
  • 10-Yr Bond

    1.5090
    +0.0290 (+1.96%)
     
  • Vix

    20.14
    -1.75 (-7.99%)
     
  • GBP/USD

    1.3233
    -0.0009 (-0.0662%)
     
  • USD/JPY

    113.6620
    +0.1220 (+0.1075%)
     
  • BTC-USD

    50,667.62
    +267.84 (+0.53%)
     
  • CMC Crypto 200

    1,321.87
    +16.75 (+1.28%)
     
  • FTSE 100

    7,337.05
    -2.85 (-0.04%)
     
  • Nikkei 225

    28,860.62
    +405.02 (+1.42%)
     

Tandem Diabetes Care to Announce Third Quarter 2021 Financial Results on November 3, 2021

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

SAN DIEGO, October 07, 2021--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2021 results after the financial markets close on Wednesday, November 3, 2021. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its third quarter 2021 financial and operating results.

Conference Call/Webcast Details:

Date: November 3, 2021
Time: 4:30 pm Eastern Time (1:30 pm Pacific Time)
Toll Free Dial-In Number: (855) 427-4396
International Dial-In Number: (484) 756-4261
Conference ID: 4679227
Webcast Link: https://edge.media-server.com/mmc/p/tjyiohyv

An archive of the webcast will be available for 30 days following the event on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the "Events & Presentations" section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem’s flagship product, the t:slim X2™ insulin pump, is capable of remote software updates using a personal computer and features integrated continuous glucose monitoring, and optional automated insulin delivery technology. Tandem is based in San Diego, California.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes, use #tslimX2 and $TNDM.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at www.linkedin.com/company/TandemDiabetes.

Tandem Diabetes Care is a registered trademark and t:slim X2 is a trademark of Tandem Diabetes Care, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211007005756/en/

Contacts

Media Contact:
Steve Sabicer
714-907-6264
ssabicer@thesabicergroup.com

Investor Contact:
Susan Morrison
858-366-6900
smorrison@tandemdiabetes.com